![Tanja Weber](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Tanja Weber formerly worked at Agios Pharmaceuticals, Inc., as Vice President-Business Development, Sanofi Ventures, as Vice President-Business Development, and Epizyme, Inc., as SVP-Business Development & Alliance Management from 2019 to 2022.
Ms. Weber received her graduate degree from Ruprecht-Karls-Universität Heidelberg.
Anciens postes connus de Tanja Weber
| Sociétés | Poste | Fin |
|---|---|---|
| EPIZYME, INC. | Corporate Officer/Principal | 01/03/2022 |
| AGIOS PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
Sanofi Ventures
 Sanofi Ventures Investment ManagersFinance Sanofi Ventures invests in companies located in the United States. The firm targets companies operating in the fields of biotech and digital health sectors. It provides financing for seed and early stage capital requirements. It acts as lead investor and also takes a seat on board of directors. | Corporate Officer/Principal | - |
Formation de Tanja Weber
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
23
Relations au 1er degré
4
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Agios Pharmaceuticals, Inc.
 Agios Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops therapeutics | Health Technology |
Ruprecht-Karls-Universität Heidelberg
 Ruprecht-Karls-Universität Heidelberg Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sanofi Ventures
Sanofi Ventures Investment ManagersFinance Sanofi Ventures invests in companies located in the United States. The firm targets companies operating in the fields of biotech and digital health sectors. It provides financing for seed and early stage capital requirements. It acts as lead investor and also takes a seat on board of directors. | Finance |
Epizyme, Inc.
 Epizyme, Inc. BiotechnologyHealth Technology Develops therapeutics for the treatment of patients with genetically defined cancers | Health Technology |
